Machine Learning for Therapeutic Protein Design

Generate:Biomedicines is at the forefront of therapeutic innovation, leveraging a unique platform that integrates machine learning and biological engineering to revolutionize drug development. Their approach, termed generative biology, allows for the systematic generation of novel proteins with specific therapeutic functions by analyzing millions of existing proteins to uncover the underlying principles of biological function. This capability enables the rapid creation of medicines across various modalities, including antibodies, peptides, and enzymes, significantly enhancing the speed and success rates of drug discovery compared to traditional methods.

The Generate Platform operates as a continuous feedback loop that encompasses the generation, building, measurement, and learning of protein sequences. By employing advanced algorithms, the platform can produce real proteins at scale and assess their molecular characteristics and functions through next-generation systems. This iterative process not only accelerates the identification and validation of therapeutics but also allows for the optimization of protein properties, such as enhancing enzyme specificity or creating stealth proteins that evade immune detection. Overall, Generate:Biomedicines is pioneering a transformative approach to biomedicine, aiming to address some of the most challenging health issues with unprecedented efficiency and precision.

United States

Generate:Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering generative biology to create breakthrough medicines.

Through The Generate Platform, we are able to expand the breadth of technical possibilities in order to fundamentally change the way medicines are made.

Generate:Biomedicines

Company Details